NYSEAM:VTAK - Post Discussion
Post by
averagepennies on Jan 17, 2024 9:29am
Catheter Precision’s VIVO System Featured in Electrophysiolo
FORT MILL, SC / ACCESSWIRE / January 17, 2024 / Catheter Precision, Inc. (the "Company") (NYSE American:VTAK), a leader in non-invasive 3D mapping for ventricular arrhythmias, announced that their VIVO System was highlighted as part of a case study in the current issue of EP Lab Digest. EP Lab Digest is an educational, monthly publication dedicated to electrophysiology with both print and online content.
"Physicians often present case studies to publications for new and innovative products." Said David Jenkins, CEO of Catheter Precision. "Having a case study selected means that the publication committee believes the work presented by the physicians at NYU is valuable for other electrophysiologists. This case study is unique in that it falls under a physician-initiated study and combines two different mapping platforms further streamlining the benefits of pre-procedural planning."
https://www.accesswire.com/825550/catheter-precisions-vivo-system-featured-in-electrophysiology-publication
Be the first to comment on this post